Vascular Stent Market by Type, Material, Mode of Delivery, Product, End-User

List of Tables

The Vascular Stent Market was valued at USD 21.34 billion in 2023, expected to reach USD 24.13 billion in 2024, and is projected to grow at a CAGR of 13.54%, to USD 51.93 billion by 2030.

The vascular stent market encompasses the development and distribution of medical devices used to treat narrowed or blocked blood vessels. These stents are critical in managing cardiovascular diseases, offering essential support to open arteries and veins, thus ensuring proper blood flow. With increasing instances of coronary artery disease and peripheral artery disease, driven by lifestyle changes and growing aging populations, the application of vascular stents in medical procedures becomes crucial. End-use sectors primarily include hospitals, ambulatory surgical centers, and specialized cardiac centers, with a significant impetus from advancements in minimally invasive procedures further driving market demand.

KEY MARKET STATISTICS
Base Year [2023]	USD 21.34 billion
Estimated Year [2024]	USD 24.13 billion
Forecast Year [2030]	USD 51.93 billion
CAGR (%)	13.54%

Key growth factors influencing this market include technological advancements in stent design, such as drug-eluting stents, which enhance patient outcomes by reducing restenosis rates. Additionally, the integration of bioresorbable and fully degradable stent technologies showcases potential opportunities for future innovation. The increasing prevalence of lifestyle disorders, coupled with rising healthcare expenditures and awareness regarding early intervention in vascular complications, further propels market demand. However, limitations such as high costs associated with advanced stent technologies, regulatory hurdles, and potential complications such as stent thrombosis present challenges to market growth.

Innovation opportunities lie in developing biodegradable stents and integrating artificial intelligence for personalized treatment planning and improved patient monitoring. A key area for research is enhancing the biocompatibility and functionality of stents to cater to diverse patient needs. The competitive nature of the market necessitates continuous research, focusing on new material development and non-invasive treatment methods to maintain leadership and market relevance. Companies should aim to leverage strategic partnerships and investments in R&D for product diversification and to enhance market penetration. Addressing affordability and securing favorable reimbursement policies will also be vital to fostering broader adoption, especially in emerging markets with growing healthcare infrastructures.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vascular Stent Market

The Vascular Stent Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Increasing prevalence of vascular diseases and growth in geriatric population
- Expanding health insurance coverage makes surgical procedures more accessible,
- Rising demand for minimally invasive medical procedures
Market Restraints
- Availability of alternative medical treatments and product recalls
Market Opportunities
- Rising focus on bioresorbable stents developments
- Increasing collaborative strategic initiatives for business expansion
Market Challenges
- Complications associated with the stent implementation

Porter's Five Forces: A Strategic Tool for Navigating the Vascular Stent Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vascular Stent Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vascular Stent Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vascular Stent Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vascular Stent Market

A detailed market share analysis in the Vascular Stent Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vascular Stent Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vascular Stent Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vascular Stent Market

A strategic analysis of the Vascular Stent Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vascular Stent Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Medical, Inc, CryoLife, Inc., Elixir Medical Corporation, Endologix, Inc., Medtronic PLC, Meril Life Sciences Pvt. Ltd, Microport Scientific Corporation, Purple Medical Solution Pvt. Ltd, Sahajanand Medical Technologies Pvt. Ltd, Stryker Corporation, Terumo Corporation, Veryan Medical Limited., and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Vascular Stent Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Type, market is studied across Bare Metal Stent, Bio-Engineered Stent, Drug Eluting Stent, and Dual Therapy Stent.
Based on Material, market is studied across Metallic Stent and Polymer.
Based on Mode of Delivery, market is studied across Balloon-Expandable Stent and Self-Expanding Stent.
Based on Product, market is studied across Coronary Stent, Evar Stent Graft, and Peripheral Stent. The Evar Stent Graft is further studied across Abdominal Aortic Aneurysm and Thoracic Aortic Aneurysm. The Peripheral Stent is further studied across Carotid Stent, Femoral Stent, Iliac Stent, and Renal Artery Stent.
Based on End-User, market is studied across Ambulatory Surgical Center, Cardiac Center, and Hospital.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-034B5003037F

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing prevalence of vascular diseases and growth in geriatric population
  - 5.1.1.2. Expanding health insurance coverage makes surgical procedures more accessible,
  - 5.1.1.3. Rising demand for minimally invasive medical procedures
- 5.1.2. Restraints
  - 5.1.2.1. Availability of alternative medical treatments and product recalls
- 5.1.3. Opportunities
  - 5.1.3.1. Rising focus on bioresorbable stents developments
  - 5.1.3.2. Increasing collaborative strategic initiatives for business expansion
- 5.1.4. Challenges
  - 5.1.4.1. Complications associated with the stent implementation
5.2. Market Segmentation Analysis
- 5.2.1. End-Users: Adoption of vascular stent in ambulatory surgical centers for high-quality care and rapid recovery
- 5.2.2. Product: Utilisation of iliac stents for prevention of complications such as claudication and limb ischemia
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Vascular Stent Market, by Type

6.1. Introduction
6.2. Bare Metal Stent
6.3. Bio-Engineered Stent
6.4. Drug Eluting Stent
6.5. Dual Therapy Stent

7. Vascular Stent Market, by Material

7.1. Introduction
7.2. Metallic Stent
7.3. Polymer

8. Vascular Stent Market, by Mode of Delivery

8.1. Introduction
8.2. Balloon-Expandable Stent
8.3. Self-Expanding Stent

9. Vascular Stent Market, by Product

9.1. Introduction
9.2. Coronary Stent
9.3. Evar Stent Graft
- 9.3.1. Abdominal Aortic Aneurysm
- 9.3.2. Thoracic Aortic Aneurysm
9.4. Peripheral Stent
- 9.4.1. Carotid Stent
- 9.4.2. Femoral Stent
- 9.4.3. Iliac Stent
- 9.4.4. Renal Artery Stent

10. Vascular Stent Market, by End-User

10.1. Introduction
10.2. Ambulatory Surgical Center
10.3. Cardiac Center
10.4. Hospital

11. Americas Vascular Stent Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Vascular Stent Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Vascular Stent Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
- 14.3.1. Boston Scientific to boost vascular portfolio and long-term growth with Silk Road Medical acquisition
- 14.3.2. Abbott introduces Xience Sierra coronary stent system for enhanced heart patient care
- 14.3.3. Strategic partnership between SMT and HeartX to revolutionize congenital heart defect treatment worldwide
14.4. Strategy Analysis & Recommendation

Companies Mentioned

1. Abbott Laboratories
2. B. Braun Melsungen AG
3. Becton, Dickinson and Company
4. Biosensors International Group, Ltd.
5. Biotronik SE & Co. KG
6. Boston Scientific Corporation
7. Cook Medical, Inc
8. CryoLife, Inc.
9. Elixir Medical Corporation
10. Endologix, Inc.
11. Medtronic PLC
12. Meril Life Sciences Pvt. Ltd
13. Microport Scientific Corporation
14. Purple Medical Solution Pvt. Ltd
15. Sahajanand Medical Technologies Pvt. Ltd
16. Stryker Corporation
17. Terumo Corporation
18. Veryan Medical Limited.
19. W. L. Gore & Associates, Inc.